“…Female endogenous and exogenous reproductive hormones, estrogen and progesterone, are known to fluctuate in concentration throughout the menstrual and oral contraceptive cycles, respectively. Estrogen, in particular, has been shown to play a significant role in the regulation of vasodilatory responses (Hellsten & Gliemann, 2018), suggesting (Gnasso et al, 2001). As measured with FMD, changes in conduit artery function across the menstrual cycle are inconsistent in the literature, with some studies showing increases in brachial artery FMD in the late follicular and midluteal phases of the menstrual cycle compared with the early follicular phase (Adkisson et al, 2010;English, Jacobs, Green, & Andrews, 1998;Harris, Tedjasaputra, Zhao, & Richardson, 2012;Hashimoto et al, 1995;Williams et al, 2001) and others reporting no change in FMD across the cycle (D'Urzo, King, Williams, Silvester, & Pyke, 2018;Jochmann et al, 2009;Rakobowchuk, Parsloe, Gibbins, Harris, & Birch, 2013;Saxena, Seely, & Goldfine, 2012;Shenouda, Priest, Rizzuto, & MacDonald, 2018).…”